Samsung Biologics, Foreign Investors Net Buy 18,507 Shares... Stock Price Up 4.79%

Samsung Biologics ranked among the top searched stocks for 16 days in the past month.

As of 12:31 PM on the 2nd, Samsung Biologics is trading at 788,000 KRW, up 4.79% from the previous day. This marks a 21.23% increase compared to June 4. Samsung Biologics is known as the holding company for Samsung Group's bio business.

Today, foreigners are tentatively recorded as net buyers of 18,507 shares. Over the past five days, individual investors have net bought 101,885 shares, while foreigners and institutions have net sold 81,917 shares and 22,450 shares, respectively.

On June 24, Samsung Biologics was a market highlight for its "strong performance following a 380 billion KRW contract signing."

[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)

※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and financial AI specialist Thinkpool.

This content was produced with the assistance of AI translation services.